Mr Soriot also played down criticism that AZ had received during the pandemic from politicians in Europe, such as the French president Emmanuel Macron, who in January this year claimed that the company's vaccine was "quasi ineffective" in the over-65s.
The AZ chief executive, who declined to comment on why Mr Macron had subsequently changed his mind, suggested that, in fact, the relatively low levels of hospitalisations now being seen in the UK compared with continental Europe might be down to the use of the AZ vaccine in older people.
He noted that, in continental Europe, older patients have mainly been vaccinated with the mRNA vaccine produced by Pfizer.
Mr Soriot added: "Continental Europe vaccinated older people mostly with the mRNA vaccine and the UK vaccinated older people mostly with our vaccine - and we'll have to see over time whether that creates a difference.
"But what is really interesting to see in the data today is that in the UK, the number of hospitalisations…has remained relatively low, even though there were lots of infections, the number of severe infections and hospitalisations was still reasonable, relative to continental Europe, where the number of hospitalisations is relatively high in some countries."
Not sure what to make of this but it’s interesting
https://news.sky.com/story/astrazenecas-pledge-to-poorer-nations-as-it-seeks-covid-jab-profits-from-next-year-12475935
Mr Soriot also played down criticism that AZ had received during the pandemic from politicians in Europe, such as the French president Emmanuel Macron, who in January this year claimed that the company's vaccine was "quasi ineffective" in the over-65s.
The AZ chief executive, who declined to comment on why Mr Macron had subsequently changed his mind, suggested that, in fact, the relatively low levels of hospitalisations now being seen in the UK compared with continental Europe might be down to the use of the AZ vaccine in older people.
He noted that, in continental Europe, older patients have mainly been vaccinated with the mRNA vaccine produced by Pfizer.
Mr Soriot added: "Continental Europe vaccinated older people mostly with the mRNA vaccine and the UK vaccinated older people mostly with our vaccine - and we'll have to see over time whether that creates a difference.
"But what is really interesting to see in the data today is that in the UK, the number of hospitalisations…has remained relatively low, even though there were lots of infections, the number of severe infections and hospitalisations was still reasonable, relative to continental Europe, where the number of hospitalisations is relatively high in some countries."